QSAR analysis of 6-aryl-2,4-dioxo-5-hexenoic acids as HIV-1 integrase inhibitors

Indian Journal of Pharmaceutical Education and Research

Volumn 42, Issue 2, 2008, Pages 133-140

  Ravichandran, V ^a   Mourya, V K ^b   Agrawal, R K ^a  

^a DR H S GOUR UNIVERSITY   (India)

^b GOVERNMENT COLLEGE OF PHARMACY   (India)

Author keywords

Hexenoic acid; Human immunodeficiency virus; Inhibition; Integrase; Quantitative structure activity relationship

Indexed keywords

6 ARYL 2,4 DIOXO 5 HEXENOIC ACID DERIVATIVE; INTEGRASE INHIBITOR; UNCLASSIFIED DRUG;

ANALYTICAL ERROR; ARTICLE; BIOLOGICAL ACTIVITY; CALCULATION; DRUG STRUCTURE; IC 50; PARTITION COEFFICIENT; PREDICTION; QUANTITATIVE STRUCTURE ACTIVITY RELATION;

EID: 67650622420     PISSN: 00195464     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. De Clercq E. Toward improved anti-HIV chemotherapy: therapeutic strategies for intervention with HIV infections. J Med Chem 1995;38:2491-517.
2. Craigie R, Fujiwara T, Bushman F. The IN protein of Moloney murine leukemia virus processes the DNA viral ends and accomplishes their integration in vitro. Cell 1990; 62:829-35.
3. Katz RA, Merkel G, Kulkosk T, Leis J, Salka AM. The avian retroviral IN protein is both necessary and sufficient for integrative recombination in vitro. Cell 1990;63:87-91.
4. Chen IJ, Neamati N, Nicklaus MC et al. Identification of HIV-1 integrase inhibitors via three-dimensional database searching using ASV and HIV-1 integrases as targets. Bioorg Med Chem 2000;8: 2385-90.
5. Neamati N. Patented small molecule inhibitors of HIV-1 integrase: a 10-year saga. Expert Opin Ther Patents 2002;12:709.
6. Parril AL. HIV-1 integrase inhibition: binding sites, structure activity relationships and future perspectives. Curr Med Chem 2003;10:1811-15.
7. Carteau S, Mouscadet JF, Goulaouic H, Subra F, Auclair C. Effect of topoisomerase inhibitors on the in vitro HIV DNA integration reaction. Biochem Biophys Res Commun 1993;192:1409-13.
8. Fesen MR, Kohn KW, Leteurtre F, Pommier Y. Inhibitors of human immunodeficiency virus integrase. Proc Natl Acad Sci USA 1993;90:2399-03.
9. Mouscadet JF, Carteau S, Goulaouic H, Subra F, Auclair C. Triplex-mediated inhibition of HIV DNA integration in vitro. J Biol Chem 1994;269:21635-8.
10. Eich E, Pertz H, Kaloga M, Schulz J, Fesen MR, Mazumder A, Pommier Y. Arctigenin as a lead structure for inhibitors of human immunodeficiency virus type-1 integrase. J Med Chem 1996;39:86-92.
11. Mazumder A, Raghawan K, Weinstein J, Kohn KW, Pommier Y. Inhibition of human immunodeficiency virus type-1 integrase by curcumin. Biochem Pharmacol 1995;49:1165-70.
12. Cushman M, Sherman P. Inhibition of HIV-1 integration protein by aurintricarboxylic acid monomers, monomer analogs, and polymer fractions. Biochem Biophys Res Commun 1992;185:58-63.
13. Robinson WE Jr, Cordeiro M, Abdel-Malek S et al. Dicaffeoylguinic acid inhibitors of human immunodeficiency virus integrase: inhibition of the core catalytic domain of human immunodeficiency virus integrase. Mol Pharmacol 1996;50:846-50.
14. Robinson WE Jr, Reineck MG, Abdel-Malek S, Jia Q, Chow SA. Inhibitors of HIV-1 replication inhibit HIV integrase. Proc Natl Acad Sci USA 1996;93:6326-32.
15. Mazumder A, Neamati N, Sommadossi JP, Gosseli G, Schinazi RF, Pommier Y. Effects of nucleotide analogues on human immunodeficiency virus type 1 integrase. Mol Pharmacol 1996;49:621-6.
16. Hansch C. A quantitative approach to biochemical structure-activity relationships. Acc Chem Res 1969;2:232-8.
17. Pungpo P, Hannongbua S. Three-dimensional quantitative structure-activity relationships study on HIV-1 reverse transcriptase inhibitors in the class of dipyridodiazepinone derivatives, using comparative molecular field analysis. J Mol Graphics & Model 2000;18:581-90.
18. Ravichandran V, Agrawal RK. Predicting anti-HIV activity of PETT derivatives: CoMFA approach. Bioorg Med Chem Lett 2007;17:2197-02.
19. Barreca ML, Carotti A, Chimirri A, Monforte AM. Comparative molecular field analysis (CoMFA) and docking studies of nonnucleoside HIV-1 RT inhibitors (NNIS), Bioorg Med Chem 1999;7:2283-92.
20. Ravichandran V, Mourya VK, Agrawal RK. QSAR study of novel 1, 1, 3 - trioxo [1, 2, 4] -thiadiazine (TTDs) analogues as potent anti-HIV agents. Arkivoc 2007;XIV:204-12.
21. Costi R, Santo RD, Artico M et al. 6-Aryl-2,4-dioxo-5-hexenoic acids, novel integrase inhibitors active against HIV-1 multiplication in cell-based assays. Bioorg Med Chem Lett 2004;14:1745-9.